
|Articles|January 1, 2005
New guidelines answer questions in the hormone-replacement debate
When Common wisdom is debunked, it takes time for physicians and their patients to adjust to a new way of thinking. Hormone therapy (HT) is just beginning to emerge from that state of limbo.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Pashtoon Kasi, M.D., on daraxonrasib's impact on patients: 'You have to see it to believe it' | ASCO 2026
2
New app connects pain patients to doctors
3
Joanne Mortimer, M.D., on associations between GLP-1 use and cancer outcomes | ASCO 2026
4
American Cancer Society adds blood and stool tests to colorectal screening guideline
5




























